Notably, a small percentage of patients with clinical BHD syndrome manifestations may not have detectable FLCN variants with conventional sequencing methods, while NGS provides a comprehensive molecular diagnosis by identifying exonic and intronic small nucleotide variants, small indels, and large intragenic deletions [35,36,37]. This evidence concerns the gene FLCN and Birt-Hogg-Dubé syndrome.